Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer.
about
Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified.Incidence and consequences of bone metastases in lung cancer patients.Treatment complexity: a description of chemotherapy and supportive care treatment visits in patients with advanced-stage cancer diagnoses.miR-137 inhibits the proliferation of human non-small cell lung cancer cells by targeting SRC3.Darkness before dawn, but will the sun always rise?Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011.
P2860
Impact of new chemotherapeutic and targeted agents on survival in stage IV non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Impact of new chemotherapeutic ...... IV non-small cell lung cancer.
@ast
Impact of new chemotherapeutic ...... IV non-small cell lung cancer.
@en
type
label
Impact of new chemotherapeutic ...... IV non-small cell lung cancer.
@ast
Impact of new chemotherapeutic ...... IV non-small cell lung cancer.
@en
prefLabel
Impact of new chemotherapeutic ...... IV non-small cell lung cancer.
@ast
Impact of new chemotherapeutic ...... IV non-small cell lung cancer.
@en
P2093
P2860
P1433
P1476
Impact of new chemotherapeutic ...... IV non-small cell lung cancer.
@en
P2093
Christine Simmons
J Charles Victor
Joanne L Yu
Natasha Leighl
Sophie Hogeveen
Sunil Verma
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0079
P577
2011-08-11T00:00:00Z